After fessing up in August 2020 to conspiracy to commit mail and wire fraud against an unnamed pharmaceutical manufacturer, pharmacy operator Arkadiy Khaimov is heade...

What a difference a year makes: Pfizer and Moderna were riding high in Americans' minds last year, but a new report from The Harris Poll shows how both have fallen fr...

Kyowa Kirin International (KKI) takes highlighting awareness of rare disease X-linked hypophosphatemia (XLH) literally with its immersive virtual exhibition, the “Shi...

After socking $1 billion into a new injectables factory in North Carolina in January, Lilly is dipping back into its pocketbook for another blockbuster manufacturing ...

In the latest in a long series of pharma opioid settlements, Teva and AbbVie’s Allergan unit have reached a deal with the hard-hit state of West Virginia. Under the d...

New Jersey commuters headed for Manhattan via the Lincoln Tunnel may notice a new billboard featuring a medical worker and the caption: “It’s part of my job.” In ...

Pharma is bucking the trend that is seeing most other sectors rush to digital advertising, instead deciding to stick with TV ads. That’s according to a new report out...

It’s boots on the ground, or rather in the office, for SK Life Science’s latest sales push aimed at getting its target, i.e., neurologists, to pay attention. The ...

Moderna’s CEO Stéphane Bancel has been named a chevalier (knight) of the Légion d’Honneur, the highest French distinction for military and civil accomplishments. ...

After two FDA rejections against China-made cancer immunotherapies this year, another Chinese pharma hopes it has the data to crack the agency’s doors open. But one m...